USA: TWO NEW DRUGS DEVELOPED TO COMBAT AIDS скачать в хорошем качестве

USA: TWO NEW DRUGS DEVELOPED TO COMBAT AIDS

(8 Nov 1995) English/Nat AIDS patients may soon be able to try two promising new drugs to help combat the deadly disease. American federal scientists have voted to approve two new products - `Saquinavir' and 3TC. They will be licensed to be used in combination with already existing AIDS treatments. The Federal Drug Administration still has to back the scientists' decision, but it is thought that this final step will be a formality. Saquinavir, produced by the Swiss pharmaceutical company Hoffman Laroche, will become the first in an entirely new class of drugs called protease inhibitors. In laboratory studies it was shown that it could slow and stop the progression of AIDS by acting on a part of the virus that doctors had previously been unable to attack. Studies showed that taken with the most effective existing anti-AIDS drug AZT, Saquinavir boosted patients' immune system and reduced the amount of the virus in their blood. SOUNDBITE: (English) "The greatest progress will come in finding the right combinations. What we're seeing is that the answer is not gonna lie in any one drug - it's not going to be a magic bullet. The real hope is that with these newer agents, and with the number of agents already on the market, that the right combinations really will lead to marked responses." SUPERCAPTION: Dr. David Kessler, Food and Drug Administration Commissioner Another drug that may soon be on the market is Glaxo Wellcome's 3TC. It too has been shown to combat the advance of AIDS successfully if used with AZT. It would give AIDS sufferers the best new hope in treatment since AZT came on the scene in 1987. SOUNDBITE: (English) " I'm aware that if I took this drug, that I may get resistance that it might not benefit me at all. At least I have that choice. So I think the company that is promoting these drugs should basically open it up to expanded access. SUPERCAPTION: Dr. Stephen Kinney, AIDS sufferer and FDA adviser. Despite the welcome from scientists and many AID's campaigners, some AIDS activists are still wary. They fear that swift approval by the FDA may encourage drug manufacturers to market new drugs without adequate testing. Find out more about AP Archive: http://www.aparchive.com/HowWeWork Twitter:   / ap_archive   Facebook:   / aparchives   ​​ Instagram:   / apnews   You can license this story through AP Archive: http://www.aparchive.com/metadata/you...